PAVmed (PAVM) majority-owned subsidiary Lucid Diagnostics to spin-off into separate public company

Go back to PAVmed (PAVM) majority-owned subsidiary Lucid Diagnostics to spin-off into separate public company

PAVmed (PAVM) Prices 9.8M Share Common Offering for Gross Proceeds of Approx. $45M

February 23, 2021 9:03 AM EST

PAVmed Inc. (NASDAQ: PAVM) today announced the pricing of its previously announced underwritten public offering (the Offering) of approximately 9.8 million shares of its common stock for gross proceeds of approximately $45 million, before deducting the underwriting discounts and commissions and other estimated offering expenses payable by PAVmed. The Offering is expected to close on or about February 25, 2021, subject to customary closing conditions. In addition, PAVmed has granted the... More